Research Tree Research Tree Logo

  • Try our Investor Tool
  • Login
  • Sign Up
  • Providers
  • Companies

Research Tree Logo

  • Features
  • Pricing
  • RNS/News
  • Contact
  • Try our Investor Tool
  • Login
  • Sign Up
  • Providers
  • Companies
  • Features
  • Pricing
  • RNS/News
  • Blogs
    • Academy
    • Insights
    • News
    • Research Tree
    • The Naked Fund Manager
  • Ideas & Picks
    • Ideas Hub
    • Stock Pick League
    • Themes & Screens Hub
  • Explore Content
    • Regions
      UK Rest of EMEA N America APAC LatAm
    • Sectors
      Automobile Industry Banks Building & Construction Chemicals Discretionary Personal Goods Discretionary Retail Energy Financial Services Food & Drink Food Production Health Household Goods & DIY Industrial Equipment, Goods & Services Insurance & Reinsurance Leisure, Tourism & Travel Media Other Real Estate Resources Staple Retail Technology Telecoms Trusts, ETFs & Funds Utilities
    • Small / Large Cap
      UK100 UK250 UK Smallcap UK Other Main Markets Other
  • Providers
    • Free/Commissioned
      Align Research BRR Media Capital Access Research Capital Network Edison Equity Development Five Minute Pitch TV Hardman & Co Independent Investment Research piworld.co.uk Progressive Equity Research QuotedData Radnor Capital Partners Research Tree Trinity Delta
    • Video/Audio Interviews
      BRR Media Capital Network Edison Equity Development Five Minute Pitch TV piworld.co.uk Research Tree
    • Institutional Offering
      Allenby Capital AlphaValue Arden Partners finnCap GMP FirstEnergy Hybridan Liberum N+1 Singer Northland Capital Partners SP Angel Stockdale Securities VSA Capital Whitman Howard Zeus Capital
    • High Net Worth Offering
      Allenby Capital AlphaValue Arden Partners finnCap GMP FirstEnergy Hybridan Liberum Louis Capital Marten & Co Medley Global Advisors N+1 Singer Northland Capital Partners SP Angel Stockdale Securities Tamesis Partners VSA Capital Whitman Howard Zeus Capital
  • Contact
Companies >
UK >
Pharmaceuticals >
Synairgen >
Research >
Final results; strong prospects but 2016 set to be a quiet year

  • 22 Mar 2016

Final results; strong prospects but 2016 set to be a quiet year


Synairgen | SNG | 13.0 0 0.0% | Mkt Cap: 11.9m


  • N+1 Singer
    • Sheena Berry

    • 3 pages

Pharmaceuticals image


 
Pharmaceuticals image


The main highlights for Synairgen in 2015 were the research collaboration with Pharmaxis and AstraZeneca commencing its Phase IIa trial of AZD9412 (formally SNG001). News flow from both is expected in 2017 with the former commencing clinical trials and the later announcing data. The group has also announced positive, albeit very early, data from its collaboration with Pharmaxis this morning. Synairgen continues to screen for new opportunities and expects to establish at least one in the coming y ....

Sign up to access

Get access to our full offering from over 30 providers

Get access to our full offering from over 30 providers

Get Started
Already a member? Log in here
See all the research we have on this company.

More Content

More Content

Morning Note

Companies: Synairgen Water Intelligence

finnCap

Most popular equity research this week | 20 - 24 Nov

Companies: TUISDYXARPRMSGMPHTMLIDAPHAGLAGYEMRSNGTSTLCTHODXTCGSFRSDIDOTDBVXPCOGNIPTABZAOPTIGLEMTFBIHCOTBSTXRTHMAVCTAKR

Research Tree

Year-end cash ample to complete Phase IIa

Companies: Synairgen

finnCap

Rude Health

Companies: ABZA AKR AGY APH AGL AVCT BVXP COG CTH IHC LID MTFB ODX OPTI NIPT PRM SDI STX SNG TSTL

finnCap

Morning Song

Companies: SPA BUR CBP OXB SNG ZIN

N+1 Singer

Useful Links

  • Features
  • Pricing
  • RNS/Newswires Feeds
  • Providers Hub
  • Company Hub

Account

  • Login
  • Free Trial - Join Now
  • Contact
Follow us on Linkedin Follow us on Twitter

Share:

Heap | Mobile and Web Analytics

Copyright © 2018 Research Tree | All Rights Reserved. | Terms of Service and Privacy Policy and Statement on Cookies

Research Tree will never share your details with third parties for marketing purposes. Research Tree distributes research documents that have been produced and approved by Financial Conduct Authority (FCA) Authorised & Regulated firms as well as relevant content from non-authorised sources, who are not regulated but the information is in the public domain. For the avoidance of doubt Research Tree is not giving advice, nor has Research Tree validated any of the information.

Research Tree is an Appointed Representative of Sturgeon Ventures which is Authorised and Regulated by the Financial Conduct Authority.

Tools licensed and contents implemented and optimized by Digital Look Ltd.

DigitalLook |Web Financial Group

©1999-2013 – Digital Look Ltd. A Web Financial Group Company All rights reserved. Legal notice.

Top
  • Home
  • Features
  • Pricing
  • RNS/News
  • Blogs
    • Academy
    • Insights
    • News
    • Research Tree
    • The Naked Fund Manager
  • Ideas & Picks
    • Ideas Hub
    • Stock Pick League
    • Themes & Screens Hub
  • Explore Content
    • Regions
      • UK
      • Rest of EMEA
      • N America
      • APAC
      • LatAm
    • Sectors
      • Automobile Industry
      • Banks
      • Building & Construction
      • Chemicals
      • Discretionary Personal Goods
      • Discretionary Retail
      • Energy
      • Financial Services
      • Food & Drink
      • Food Production
      • Health
      • Household Goods & DIY
      • Industrial Equipment, Goods & Services
      • Insurance & Reinsurance
      • Leisure, Tourism & Travel
      • Media
      • Other
      • Real Estate
      • Resources
      • Staple Retail
      • Technology
      • Telecoms
      • Trusts, ETFs & Funds
      • Utilities
    • Small / Large Cap
      • UK100
      • UK250
      • UK Smallcap
      • UK Other Main Markets
      • Other
  • Providers
    • Free/Commissioned
      • Align Research
      • BRR Media
      • Capital Access Research
      • Capital Network
      • Edison
      • Equity Development
      • Five Minute Pitch TV
      • Hardman & Co
      • Independent Investment Research
      • piworld.co.uk
      • Progressive Equity Research
      • QuotedData
      • Radnor Capital Partners
      • Research Tree
      • Trinity Delta
    • Video/Audio Interviews
      • BRR Media
      • Capital Network
      • Edison
      • Equity Development
      • Five Minute Pitch TV
      • piworld.co.uk
      • Research Tree
    • Institutional Offering
      • Allenby Capital
      • AlphaValue
      • Arden Partners
      • finnCap
      • GMP FirstEnergy
      • Hybridan
      • Liberum
      • N+1 Singer
      • Northland Capital Partners
      • SP Angel
      • Stockdale Securities
      • VSA Capital
      • Whitman Howard
      • Zeus Capital
    • High Net Worth Offering
      • Allenby Capital
      • AlphaValue
      • Arden Partners
      • finnCap
      • GMP FirstEnergy
      • Hybridan
      • Liberum
      • Louis Capital
      • Marten & Co
      • Medley Global Advisors
      • N+1 Singer
      • Northland Capital Partners
      • SP Angel
      • Stockdale Securities
      • Tamesis Partners
      • VSA Capital
      • Whitman Howard
      • Zeus Capital
  • Contact
  • Sign Up
  • Sign In